Adverse reproductive and developmental effects in Xenopus from insufficient Boron

Biological Trace Element Research

Volumn 66, Issue 1-3, 1998, Pages 237-259

  Fort, Douglas J ^a   Propst, Timothy L ^a   Stover, Enos L ^a   Strong, Philip L ^b   Murray, F Jay ^c  

^a Stover Group   (United States)

^b Rio Tinto Group   (United States)

^c Murray and Associates   (United States)

Author keywords

Boron; Depletion; Development; Essentiality; FETAX; Frogs; Reproduction; Xenopus

Indexed keywords

BORON;

ADOLESCENT; CONFERENCE PAPER; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; EMBRYO; EMBRYOTOXICITY; FERTILITY; LARVA; NONHUMAN; NUTRITIONAL DEFICIENCY; REPRODUCTIVE TOXICITY; TERATOGENICITY; XENOPUS;

AMPHIBIA; ANURA; XENOPUS LAEVIS;

EID: 0032447548     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02783141     Document Type: Conference Paper

References (33)

1. 1. F. J. Murray, A human health risk assessment of boron (boric acid and borax) in drinking water, Reg. Toxicol. Pharmacol. 22, 221-230 (1995).
2. 2. F. H. Nielsen, The saga of boron in food: from a banished food preservative to a beneficial nutrient in for humans, Curr. Top. Plant Biochem. Physiol. 10, 274-286 (1991).
3. 3. F. H. Nielsen, Facts and fallacies about boron, Nutr. Today 23, 6-12 (1992).
4. 4. F. H. Nielsen, Biochemical and physiological consequences of boron deprivation in humans, Environ. Health Perspect. 102, 59-63 (1994).
5. 5. W. Mertz, Essential trace metals: new definitions based on new paradigms, Nutr. Rev. 51, 287-291 (1993).
6. 6. C. D. Hunt, The biochemical effects of physiologic amounts of dietary boron in animal nutritional models, Environ. Health Perspect. 102, 35-43 (1994).
7. 7. J. N. Dumont, T. W. Schultz, M. Buchanan, and G., Kai, Frog embryo teratogenesis assay: Xenopus-a short-term assay applicable to complex mixtures, in Symposium on the Supplication of Short-Term Bioassays in the Analysis of Complex Environmental Mixtures III, M. D. Waters, S. S. Sandhu, J. Lewtas, L. Claxton, N. Chernoff, and S. Nesnow, eds., Plenum, New York, pp. 393-405 (1983).
8. 8. D. J. Fort, D. A. Dawson, and J. A. Bantle, Evaluation of the development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX), Teratogen. Carcinogen. Mutagen. 8, 251-263 (1988).
9. 9. D. A. Dawson, D. J. Fort, G. L. Smith, D. L. Newell, and J. A. Bantle, Comparative evaluation of the developmental toxicity of nicotine and cotinine with FETAX, Teratogen. Carcinogen. Mutagen. 8, 329-388 (1988).
10. 10. D. J. Fort, B. L. James, and J. A. Bantle, Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX), J. Appl. Toxicol. 9, 377-389 (1989).
11. 11. D. J. Fort and J. A. Bantle, Use of frog embryo teratogenesis assay - Xenopus (FETAX) and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin, Fundam. Appl. Toxicol. 14, 20-733 (1990).
12. 12. D. J. Fort and J. A. Bantle, Analysis of the mechanism of isoniazid-induced developmental toxicity with frog embryo teratogenesis assay - Xenopus (FETAX), Teratogen. Carcinogen. Mutagen. 10, 463-476 (1990).
13. 13. D. J. Fort, J. R. Rayburn, D. J. DeYoung, and J. A. Bantle, Assessing the efficacy of an Aroclor 1254-induced exogenous metabolic activation system for FETAX, Drug Chem. Toxicol. 14, 143-161 (1991).
14. 14. D. J. Fort, J. R. Rayburn, and J. A. Bantle, Mechanisms of acetaminophen-induced developmental toxicity in vitro, Drug Chem. Toxicol. 15, 329-350 (1992).
15. 15. D. J. Fort, E. L. Stover, J. R. Rayburn, M. A. Hull, and J. A. Bantle, Evaluation of the developmental toxicity of trichloroethylene and detoxification metabolites using Xenopus, Teratogen. Carcinogen. Mutagen. 13, 35-45 (1993).
16. 16. D. J. Fort, E. L. Stover, T. L. Propst, and J. A. Bantle, Evaluation of the developmental toxicities of theophylline, dimethyluric acid, and methylxanthine metabolites using FETAX, Drug Chem. Toxicol. 19, 267-278 (1996).
17. 17. D. J. Fort, E. L. Stover, T. L. Propst, M. A. Hull, and J. A. Bantle, Evaluation of the toxicities of coumarin, 4-hydroxycoumarin, and 7-hydroxycoumarin using FETAX, Drug Chem. Toxicol.
18. 18. G. Greenhouse, The evaluation of toxic effect of chemicals in fresh water by using frog embryos and larvae, Environ. Contam. Toxicol. 20, 93-95 (1978).
19. 19. D. A. Dawson and J. A. Bantle, Development of a reconstituted water medium and initial validation of FETAX, J. Appl. Toxicol. 7, 237-244 (1987).
20. 20. J. A. Bantle, D. A. Dawson, and D. J. Fort, Identification of developmental toxicants using the frog embryo teratogenesis assay - Xenopus (FETAX), Hydrobiologia 188/189, 577-585 (1989).
21. 22. D. A. Dawson, D. J. Fort, D. L. Newell, and J. A. Bantle, Developmental toxicity testing with FETAX: evaluation of five validation compounds, Drug Chem. Toxicol. 12, 67-76 (1989).
22. 22. J. A. Bantle, D. J. Fort, J. R. Rayburn, D. J. DeYoung, and S. J. Bush, Further validation of FETAX: evaluation of the development toxicity of five known mammalian teratogens and non-teratogens, Drug Chem. Toxicol. 13, 267-283 (1990).
23. 23. D. J. DeYoung, J. A. Bantle, and D. J. Fort, Assessment of the developmental toxicity of ascorbic acid, sodium selenate, coumarin, serotonin and 13-cis retinoic acid using FETAX, Drug Chem. Toxicol. 14, 127-143 (1991).
24. 24. Standard Guide for Conducting the Frog Embryo Teratogenesis Assay - Xenopus (FETAX), American Society for Testing and Materials (ASTM), E1439-91 (1991).
25. 25. J. A. Bantle, J. N. Dumont, R. A. Finch, G. Linder, and D. J. Fort, Atlas of Abnormalities: A Guide for the Performance of FETAX, 2nd Ed., Oklahoma State University Press, Stillwater, Oklahoma (1998).
26. 26. T. D. Sabourin and R. T. Faulk, Comparative evaluation of a short-term test for developmental effects using frog embryos, Branbury Report 26: Developmental Toxicology: Mechanisms and Risk, pp. 203-223 (1987).
27. 27. C. L. Courchesne and J. A. Bantle, Analysis of the activity of DNA, RNA, and protein synthesis inhibitors on Xenopus embryo development, Teratogen. Carcinogen. Mutagen. 5, 177-193 (1985).
28. 28. J. N. Dumont, T. W. Schultz, and R. G. Epler, The response of the FETAX model to mammalian teratogens, Teratology 27, 39a (1983).
29. 29. J. A. Bantle, D. J. Fort, and D. A. Dawson, Bridging the gap from short-term teratogenesis assays to human health hazard assessment by understanding common modes of teratogenic action, in Proceedings of the 12th Aquatic Toxicology and Hazard Assessment: 12th vol., ASTM STP 1027, U. M. Cowgill and L. R. Williams, eds., American Society for Testing and Materials, Philadelphia, pp. 46-58 (1988).
30. 30. D. J. Fort and E. L. Stover, Effect of low-level copper and pentachlorophenol exposure on various early life stages of Xenopus laevis, in Proceedings of the Fifth Environmental Toxicology and Risk Assessment, ASTM STP 1306, D. A. Bengton and D. S. Henshel, eds., American Society for Testing and Materials, Philadelphia, pp. 188-203 (1996).
31. 31. D. J. Fort and E. L. Stover, Development of short-term, whole embryo assays to evaluate detrimental effects on amphibian limb development and metamorphosis using Xenopus laevis, in Proceedings of the Sixth Environmental Toxicology and Risk Assessment, ASTM STP 1317, F. J. Dwyer, T. R. Doane, and M. L. Hinman, eds., American Society for Testing and Materials, pp. 376-390 (1997).
32. 32. D. J. Fort, T. L. Propst, T. Schetter, E. L. Stover, P. L. Strong, and F. J. Murray, Teratogenic effects of insufficient boron, copper, and zinc in Xenopus, Teratology, 57, 252 (1998).
33. 33. C. D. Hunt, Dietary boron deficiency and supplementation, in Trace Elements in Laboratory Rodents, R. R. Watson, ed., CRC, Boca Raton, FL, pp. 229-253 (1996).